Markets
HIMS Watch
Hims & Hers Health
$49.32
$7.2 17.19%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Posted 112d ago -4.57% Scalped Bullish Exited
JD_Rock
@jd_rock
49.6% Winrate 0.4% Avg Gain 213.1% S&P Beat
SYMB Locked Data
112d agoScalped Exited 112d ago
some % entered at Buy it
This is a test thesis that is a placeholder for paid trades. Once you unlock this trade, you will see the actual thesis. Thank you, dont try to cheat!
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Calls
159d agoSwungBullish
up 7.07% At 5.09, Now 5.45
Contract: 35 Strike Call for May 02
I'm betting on HIMS ahead of their earnings on May 6, especially with the recent news about GLP-1 compounded semaglutide. The stock is breaking out an... Read More
Gnotz
@bulltrad...
50.1% Winrate 46.4% Avg Gain 909.5% S&P Beat
Bought HIMS Calls
161d agoSwungBullish
up 35.52% At 2.23, Exited 3.08
Contract: 45 Strike Call for Jun 20
Trims & Adds [ ] Made $396.90 in profit
[-] 160d ago
All out @ 3.08
[-] 160d ago
Trimmed 2.00 contracts @ 2.96
[+] 161d ago
Initial 5.00 contracts @ 2.23
Exited 160d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought HIMS Shares
162d agoDaytradedBullish
down -0.16% At 36.22, Exited 36.16
I'm really bullish on HIMS with the recent surge due to the telehealth access for Wegovy. Regulatory concerns are fading and the supply constraints ar... Read More
Exited 160d ago
0 0
Long
@long_gam...
45.9% Winrate 15.1% Avg Gain 135.0% S&P Beat
Bought HIMS Shares
162d agoInvestedBullish
up 29.01% At 37.8, Now 48.77
With the recent collaboration with Novo Nordisk to enhance obesity care access and affordability, I see a strong growth potential for Hims & Hers. Thi... Read More
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Shares
162d agoSwungBullish
up 72.97% At 28.6, Exited 49.47
I believe HIMS is poised for a significant run-up based on the recent technical analysis suggesting it could break through $30. The recent performance... Read More
Exited 155d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought HIMS Shares
171d agoSwungBullish
up 4.09% At 27.36, Exited 28.48
I'm finding HIMS very attractively valued right now at about $24, especially with their projected growth. Their subscriber growth is impressive, and t... Read More
Exited 163d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Shares
175d agoSwungBullish
down -6.41% At 28.54, Exited 26.71
I'm feeling bullish on HIMS due to their massively positive revenue growth projections and strategic moves, such as buying peptide manufacturing facil... Read More
Exited 168d ago
0 0
Scalp
@scalpgan...
45.7% Winrate 99.7% Avg Gain 4606.9% S&P Beat
Bought HIMS Shares
184d agoDaytradedBullish
up 7.55% At 27.42, Exited 29.49
I'm optimistic about HIMS based on the high volatility filter results, and with a positive price target, I believe it's set up for a strong short-term... Read More
Exited 182d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Shares
190d agoSwungBullish
down -16.59% At 31.29, Exited 26.1
I just bought shares of HIMS because they’re launching Eli Lilly's Zepbound on their telehealth platform, and the stock is already reacting positively... Read More
Exited 183d ago
0 0
Scalp
@scalpgan...
45.7% Winrate 99.7% Avg Gain 4606.9% S&P Beat
Bought HIMS Shares
202d agoSwungBullish
down -7.02% At 34.33, Exited 31.92
I've had solid gains trading HIMS recently. The swings on this stock have been consistent, and I confidently anticipate a price movement of about $0.5... Read More
Exited 195d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought HIMS Shares
214d agoSwungBullish
down -3.1% At 35.8, Exited 34.69
With Hims and Hers officially being added to the S&P 400, I see it as a potential catalyst for a price increase, especially with index funds now requi... Read More
Exited 205d ago
0 0
Gnotz
@bulltrad...
50.1% Winrate 46.4% Avg Gain 909.5% S&P Beat
Bought HIMS Calls
215d agoSwungBullish
down -1.68% At 3.04, Exited 2.99
Contract: 40 Strike Call for Apr 17
Exited 212d ago
0 0
Long
@long_gam...
45.9% Winrate 15.1% Avg Gain 135.0% S&P Beat
Bought HIMS Shares
219d agoSwungBullish
down -23.57% At 45.1, Exited 34.47
I believe HIMS is poised for a recovery as they continue to offer and prescribe obesity drugs with personalized dosing. The recent commentary suggests... Read More
Exited 212d ago
0 0
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought HIMS Shares
221d agoInvestedBullish
up 8.13% At 45.1, Now 48.77
I believe HIMS is positioned well despite facing recent hurdles with the FDA. Its core services and strong brand presence will continue to drive expon... Read More
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Bought HIMS Shares
225d agoSwungBullish
down -3.54% At 41.98, Exited 40.49
I believe Hims & Hers is currently undervalued following its recent stock drop. With strong revenue growth and a solid market presence outside the GLP... Read More
Exited 218d ago
0 0
TLAMB91
@tlamb91
25.6% Winrate -10.0% Avg Gain -100.9% S&P Beat
Bought HIMS Shares
225d agoDaytradedBullish
up 17.03% At 41.67, Now 48.77
TLAMB91
@tlamb91
25.6% Winrate -10.0% Avg Gain -100.9% S&P Beat
Bought HIMS Shares
225d agoDaytradedBullish
up 17.05% At 41.66, Now 48.77
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Puts
226d agoSwungBearish
down -51.84% At 5.05, Exited 2.43
Contract: 47 Strike Put for Feb 28
I believe there's a strong chance that HIMS will crush earnings, but I'm cautious about the guidance that follows. The current market dynamics, especi... Read More
Exited 223d ago
0 0
Scalp
@scalpgan...
45.7% Winrate 99.7% Avg Gain 4606.9% S&P Beat
Bought HIMS Shares
227d agoSwungBullish
down -16.98% At 49.0, Exited 40.68
I'm really bullish on Hims & Hers after seeing their impressive earnings forecasts and potential for growth in revenue due to their new product releas... Read More
Exited 219d ago
0 0
The
@themarke...
45.8% Winrate 60.8% Avg Gain 396.5% S&P Beat
Bought HIMS Shares
228d agoSwungBullish
down -16.98% At 49.0, Exited 40.68
I'm confident that HIMS will rebound sharply next week after the earnings report, especially considering the minimal impact the FDA's announcement has... Read More
Exited 219d ago
0 0
Jake__Wujastyk
@jake__wu...
49.1% Winrate 2.5% Avg Gain 43.9% S&P Beat
Bought HIMS Shares
228d agoSwungBullish
down -16.72% At 48.85, Exited 40.68
A hard rejection at the 4.618 Fib extension this week.
Exited 219d ago
0 0
itrader001
@itrader0...
57.4% Winrate 0.5% Avg Gain 58.4% S&P Beat
Bought HIMS Calls
229d agoDaytradedBullish
down -99.76% At 4.84, Now 0.01
Contract: 60 Strike Call for Mar 21
Trims & Adds [ ] Currently down $8.3K
[+] 226d ago
Added 10.00 contracts @ 3.47
[+] 229d ago
Initial 10.00 contracts @ 4.84
Stonks
@stocks
48.7% Winrate 25.2% Avg Gain 15.8% S&P Beat
Shorted HIMS Shares
229d agoSwungBearish
up 11.38% At 50.88, Exited 45.09
With the end of the Ozempic shortage, HIMS is facing a significant drop in demand for its compounded semaglutide. As the market adjusts, I believe it'... Read More
Exited 222d ago
0 0
TLAMB91
@tlamb91
25.6% Winrate -10.0% Avg Gain -100.9% S&P Beat
Bought HIMS Shares
229d agoDaytradedBullish
down -7.15% At 52.52, Now 48.77
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Shares
231d agoSwungBullish
down -40.21% At 70.06, Exited 41.89
I believe HIMS is a strong play because it continues to reach new highs. Given its disruptive business model and recent performance, holding onto this... Read More
Exited 224d ago
0 0
Degenerate
@wsb
43.7% Winrate 14.3% Avg Gain 453.1% S&P Beat
Bought HIMS Calls
231d agoSwungBullish
down -49.93% At 16.07, Exited 8.05
Contract: 42.5 Strike Call for Feb 21
I see potential in HIMS as there seems to be renewed interest around weight loss drugs, and despite the political noise, I believe the stock can conti... Read More
Exited 229d ago
0 0
Scalp
@scalpgan...
45.7% Winrate 99.7% Avg Gain 4606.9% S&P Beat
Bought HIMS Shares
231d agoSwungBullish
down -31.76% At 58.41, Exited 39.86
I’m planning to buy shares in HIMS as I believe it's a core position that I can hold and potentially see significant growth over the next few years. W... Read More
Exited 224d ago
0 0
Jake__Wujastyk
@jake__wu...
49.1% Winrate 2.5% Avg Gain 43.9% S&P Beat
Bought HIMS Shares
234d agoSwungBullish
down -16.01% At 61.09, Exited 51.31
The 4.618 extension is above at $73.85 if this still have juice left.
Exited 226d ago
0 0
Long
@long_gam...
45.9% Winrate 15.1% Avg Gain 135.0% S&P Beat
Bought HIMS Shares
235d agoSwungBullish
down -16.01% At 61.09, Exited 51.31
I just bought into HIMS because I see strong potential with their subscription model and rapid user growth. Since they serve a large market and recent... Read More
Exited 226d ago
0 0
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.